Literature DB >> 24121026

T3 enhances thyroid cancer cell proliferation through TRβ1/Oct-1-mediated cyclin D1 activation.

Anna Perri1, Stefania Catalano2, Daniela Bonofiglio2, Donatella Vizza1, Daniela Rovito2, Hongyan Qi1, Saveria Aquila2, Salvatore Panza2, Pietro Rizza2, Marilena Lanzino2, Sebastiano Andò3.   

Abstract

Several studies have demonstrated that thyroid hormone T3 promotes cancer cell growth, even though the molecular mechanism involved in such processes still needs to be elucidated. In this study we demonstrated that T3 induced proliferation in papillary thyroid carcinoma cell lines concomitantly with an up-regulation of cyclin D1 expression, that is a critical mitogen-regulated cell-cycle control element. Our data revealed that T3 enhanced the recruitment of the TRβ1/Oct-1 complex on Octamer-transcription factor-1 site within cyclin D1 promoter, leading to its transactivation. In addition, silencing of TRβ1 or Oct-1 expression by RNA interference reversed both increased cell proliferation and up-regulation of cyclin D1, underlying the important role of both transcriptional factors in mediating these effects. Finally, T3-induced increase in cell growth was abrogated after knocking down cyclin D1 expression. All these findings highlight a new molecular mechanism by which T3 promotes thyroid cancer cell growth.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  CycD1; Oct-1; Octamer-transcription factor-1; T3; TH; TRs; TRβ1; Thyroid cancer; Thyroid hormone receptor β1; cyclin D1; thyroid hormone; thyroid hormone receptor β1; thyroid hormone receptors

Mesh:

Substances:

Year:  2013        PMID: 24121026     DOI: 10.1016/j.mce.2013.10.001

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  12 in total

Review 1.  The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks.

Authors:  Karina Vázquez-Arreguín; Dean Tantin
Journal:  Biochim Biophys Acta       Date:  2016-02-10

2.  Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.

Authors:  Aurelia Vattai; Elif Akyol; Christina Kuhn; Simone Hofmann; Helene Heidegger; Franz von Koch; Kerstin Hermelink; Rachel Wuerstlein; Nadia Harbeck; Doris Mayr; Christine Spitzweg; Bettina Toth; Sven Mahner; Udo Jeschke; Nina Ditsch
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-13       Impact factor: 4.553

3.  Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.

Authors:  Sabine Heublein; Doris Mayr; Alfons Meindl; Martin Angele; Julia Gallwas; Udo Jeschke; Nina Ditsch
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

Review 4.  Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac.

Authors:  Paul J Davis; Gennadi V Glinsky; Hung-Yun Lin; John T Leith; Aleck Hercbergs; Heng-Yuan Tang; Osnat Ashur-Fabian; Sandra Incerpi; Shaker A Mousa
Journal:  Front Endocrinol (Lausanne)       Date:  2015-01-12       Impact factor: 5.555

5.  Elevated OCT1 participates in colon tumorigenesis and independently predicts poor prognoses of colorectal cancer patients.

Authors:  Yu-Peng Wang; Guo-He Song; Jian Chen; Chao Xiao; Chao Li; Lin Zhong; Xing Sun; Zhao-Wen Wang; Gui-Long Deng; Fu-Dong Yu; Ying-Ming Xue; Hua-Mei Tang; Zhi-Hai Peng; Xiao-Liang Wang
Journal:  Tumour Biol       Date:  2015-10-04

6.  POU2F1 over-expression correlates with poor prognoses and promotes cell growth and epithelial-to-mesenchymal transition in hepatocellular carcinoma.

Authors:  Yonghao Zhong; Hongyang Huang; Min Chen; Jinzhou Huang; Qingxia Wu; Guang-Rong Yan
Journal:  Oncotarget       Date:  2017-07-04

7.  E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle.

Authors:  Jing Sun; Run Shi; Sha Zhao; Xiaona Li; Shan Lu; Hemei Bu; Xianghua Ma; Chuan Su
Journal:  J Exp Clin Cancer Res       Date:  2017-03-07

8.  A novel functional interplay between Progesterone Receptor-B and PTEN, via AKT, modulates autophagy in breast cancer cells.

Authors:  Francesca De Amicis; Carmela Guido; Marta Santoro; Marilena Lanzino; Salvatore Panza; Paola Avena; Maria Luisa Panno; Ida Perrotta; Saveria Aquila; Sebastiano Andò
Journal:  J Cell Mol Med       Date:  2014-09-12       Impact factor: 5.310

9.  The regulatory interplay between Oct-1 isoforms contributes to hematopoiesis and the isoforms imbalance correlates with a malignant transformation of B cells.

Authors:  Elizaveta V Pankratova; Alexander G Stepchenko; Irina D Krylova; Tatiana N Portseva; Sofia G Georgieva
Journal:  Oncotarget       Date:  2018-07-06

10.  Genetic variations in TAS2R3 and TAS2R4 bitterness receptors modify papillary carcinoma risk and thyroid function in Korean females.

Authors:  Jeong-Hwa Choi; Jeonghee Lee; Sarah Yang; Eun Kyung Lee; Yul Hwangbo; Jeongseon Kim
Journal:  Sci Rep       Date:  2018-10-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.